 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- |||||||||| Laennec (human placenta hydrolyzate) / GC Biopharma
New P3 trial: In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop (clinicaltrials.gov) - Jul 9, 2024
P3, N=226, Not yet recruiting, Sponsor: Green Cross Wellbeing
- | Laennec (human placenta hydrolyzate) / GC Biopharma
Trial completion: Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients (clinicaltrials.gov) - Sep 23, 2013
P3, N=78, Completed, Sponsor: Ho Cheol Shin, M.D., Ph.D.
Active, not recruiting --> Completed
- || Laennec (human placenta hydrolyzate) / GC Biopharma
New P3 trial: Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients (clinicaltrials.gov) - Dec 3, 2012
P3, N=78, Completed, Sponsor: Ho Cheol Shin, M.D., Ph.D.